Please use this identifier to cite or link to this item: doi:10.22028/D291-38964
Volltext verfügbar? / Dokumentlieferung
Title: Can toxicokinetics of (synthetic) cannabinoids in pigs after pulmonary administration be upscaled to humans by allometric techniques?
Author(s): Schaefer, Nadine
Wojtyniak, Jan-Georg
Kroell, Ann-Katrin
Koerbel, Christina
Laschke, Matthias W.
Lehr, Thorsten
Menger, Michael D.
Maurer, Hans H.
Meyer, Markus R.
Schmidt, Peter H.
Language: English
Title: Biochemical Pharmacology
Volume: 155
Pages: 403-418
Publisher/Platform: Elsevier
Year of Publication: 2018
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Being advertised and distributed as attractive substitutes of cannabis, synthetic cannabinoids (SC) are gaining increasing relevance in forensic and clinical toxicology. As no data from controlled human studies are available, SC are sold and consumed without the knowledge of their toxicokinetic (TK) and toxicodynamic properties. Hence, animal models coupled with mathematical approaches should be used to ascertain those properties. Therefore, a controlled pig TK study allowing for extrapolation to human data was performed. For this purpose, eleven pigs received a single pulmonary dose of 200 µg/kg body weight each of Δ9-tetrahydrocannabinol (THC), 4-ethylnaphthalene-1-yl-(1-pentylindole-3-yl)methanone (JWH-210) as well as 2-(4-methoxyphenyl)-1-(1-pentyl-indole-3-yl)methanone (RCS-4) via an ultrasonic nebulizer. Blood and urine samples were repeatedly drawn over 8 h. Serum-concentration-time profiles of the parent compounds were determined using LC-MS/MS. Urine specimens were analyzed by LC-HR-MS/MS in order to elucidate the main metabolites. Maximum serum concentrations were reached 10–15 min after beginning of nebulization and amounted to 66 ± 36 ng/mL for THC, 41 ± 11 ng/mL for JWH-210, and 34 ± 8.9 ng/mL for RCS-4. The serum-concentration-time profiles of THC, JWH-210, and RCS-4 were best described by three-compartment models with first order absorption and elimination processes. Absorption from the lungs to serum was modeled by first-order processes. The determination of the bioavailability yielded 23.0%, 24.2%, and 45.7% for THC, JWH-210, and RCS-4, respectively. Furthermore, the developed THC model was upscaled to humans using allometric scaling techniques. A successful prediction of human concentration-time profiles could be done. Also the metabolic patterns were in good agreement with human data. In conclusion, these findings are the first reported regarding the TK properties of SC after pulmonary administration to pigs. The presented method of TK serves as an appropriate predictor of human TK of cannabinoids.
DOI of the first publication: 10.1016/j.bcp.2018.07.029
URL of the first publication: https://doi.org/10.1016/j.bcp.2018.07.029
Link to this record: urn:nbn:de:bsz:291--ds-389647
hdl:20.500.11880/35146
http://dx.doi.org/10.22028/D291-38964
ISSN: 0006-2952
Date of registration: 8-Feb-2023
Faculty: M - Medizinische Fakultät
NT - Naturwissenschaftlich- Technische Fakultät
Department: M - Chirurgie
M - Experimentelle und Klinische Pharmakologie und Toxikologie
NT - Pharmazie
Professorship: M - Prof. Dr. Michael D. Menger
M - Prof. Dr. Markus Meyer
NT - Prof. Dr. Thorsten Lehr
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
There are no files associated with this item.


Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.